ÂÜÀòÂÒÂ×

Andrew Ditto has extensive experience in research and development, particularly in the medical device and pharmaceutical industries. Andrew has held various leadership roles in companies such as Gebauer Company, Haima Therapeutics, and Coltene Whaledent, Inc. Andrew's expertise includes innovation management, investigational drug development, FDA design controls, and EU regulatory compliance. Andrew holds a Ph.D. in Biomedical Engineering from The University of Akron and has a strong background in designing and testing medical devices.